Alosetron
- Product NDC
- 70756-701
- 11-digit product format
- 707560701
- Labeler code
- 70756
- Product ID
- 70756-701_6e1e5a99-5018-42e7-8e2c-bcd0ac1e80fb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alosetron
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lifestar Pharma LLC
- Application
- ANDA213614
- Marketing category
- ANDA
- Marketing start
- 2020-09-14
- Substance
- ALOSETRON HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alosetron
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALOSETRON HYDROCHLORIDE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2F5R1A46YW |
| Rxcui | 259306, 403975 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70756-701-30 | Alosetron | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70756-701 | ALOSETRON TABLET [LIFESTAR PHARMA LLC] | 4 | Current NDC, Legacy NDC, 1 package rows | 20220324_2846a244-7540-442b-81bc-638e641497ce.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70756-701-30 | 70756070130 | 30 TABLET in 1 BOTTLE (70756-701-30) | 30 tablet | 2020-09-14 | 0000-00-00 | No | No | Current |